Liver resection versus chemoembolization for patients with multifocal hepatocellular carcinoma

Curative intent treatment strategies for patients with hepatocellular carcinoma (HCC) include liver resection, liver transplantation, and arguably tumor ablation. Locoregional therapies including transarterial chemoembolization (TACE) as well as transarterial radioembolization (TARE) remain viable treatment options for patients who are not candidates for therapy with curative intent or patients awaiting liver transplantation receiving downstaging treatment as part of intention to proceed with transplantation.